T&L Co

T&L Co Net Debt

The Net Debt of T&L Co (340570.KQ) as of Oct 30, 2026 is -74.62 B KRW. In the previous year, Net Debt was -47.16 B KRW — a change of 58.22% (lower).

Net Debt

-74.62 BKRW

YoY

58.22%

Last updated:

Net Debt of T&L Co is 2024 -74.62 B KRW. Net Debt of T&L Co was 2023 -47.16 B KRW. It decreases by 58.22% lower compared to the previous year.

The T&L Co Net Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt
Date
Net Debt
Jan 1, 2017
4.03 B KRW
Jan 1, 2018
1.59 B KRW
Jan 1, 2019
-1.55 B KRW
Jan 1, 2020
-34.55 B KRW
Jan 1, 2021
-36.38 B KRW
Jan 1, 2022
-31.52 B KRW
Jan 1, 2023
-47.16 B KRW
Jan 1, 2024
-74.62 B KRW
The T&L Co Net Debt history
YEARNet DebtYoY
-74.62 BKRW+58.22%
-47.16 BKRW+49.62%
-31.52 BKRW-13.35%
-36.38 BKRW+5.30%
-34.55 BKRW+2,135.64%
-1.55 BKRW-197.11%
1.59 BKRW-60.56%
4.03 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

T&L Co Stock analysis

What does T&L Co do? T&L Co., Ltd. generates revenue through the sale of medical polymer material products including wound treatment materials like hydrocolloids, foams, and hydrogels, which are essential for wound healing. The company also offers orthopedic fixing materials such as casts and splints for fracture treatment, alongside structural adhesives and water repellents. Domestic and international markets, particularly the United States, Germany, China, and Dubai, purchase these products. The firm's product portfolio targets healthcare providers and medical facilities requiring specialized materials for patient care. T&L Co., Ltd. focuses on developing medical polymer materials that serve specific clinical needs, with wound treatment materials being a key segment. Orthopedic fixing materials are sold to hospitals and clinics for fracture management, while structural adhesives and water repellents cater to industrial applications. The company's international presence in the United States, Germany, China, and Dubai supports its market diversification strategy. The firm's revenue streams are derived from the consistent demand for medical polymer products in wound care, orthopedic solutions, and industrial adhesives. Products such as hydrocolloids, foams, and hydrogels are sold to healthcare providers, while orthopedic devices like casts and splints are distributed to medical institutions. Structural adhesives and water repellents are marketed to industrial clients in key global markets. T&L Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about T&L Co stock

Net Debt of T&L Co is -74.62 B KRW in 2024.

Net Debt of T&L Co changed from -47.16 B KRW to -74.62 B KRW, representing a 58.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt T&L Co since 2006 – with annual values, charts, and detailed analysis.

Net debt is total debt minus cash and cash equivalents. It shows the actual debt burden after accounting for available liquid resources.

Net Debt's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Debt's T&L Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — T&L Co

All Key Metrics — T&L Co